MYOV
Myovant Sciences Ltd
$26.98
Earnings Summary
Revenue | $100.23Mn |
Net Profits | $-57.63Mn |
Net Profit Margins | -57.5% |
Highlights
Myovant Sciences Ltd’s revenue jumped 84.11% since last year same period to $100.23Mn in the Q4 2022. On a quarterly growth basis, Myovant Sciences Ltd has generated -4.38% fall in its revenue since last 3-months.
Myovant Sciences Ltd’s net profit jumped 9.17% since last year same period to $-57.63Mn in the Q4 2022. On a quarterly growth basis, Myovant Sciences Ltd has generated -26.32% fall in its net profits since last 3-months.
Myovant Sciences Ltd’s net profit margin jumped 50.67% since last year same period to -57.5% in the Q4 2022. On a quarterly growth basis, Myovant Sciences Ltd has generated -32.11% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Myovant Sciences Ltd post its latest quarter earnings
EPS Estimate Current Quarter | -0.47 |
EPS Estimate Current Year | -0.47 |
Highlights
Myovant Sciences Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.47 - a 4.08% jump from last quarter’s estimates.
Myovant Sciences Ltd’s earning per share (EPS) estimates for the current year stand at -0.47.
Key Ratios
Key ratios of the Myovant Sciences Ltd post its Q3 2022 earnings
Earning Per Share (EPS) | -0.47 |
Highlights
Myovant Sciences Ltd’s earning per share (EPS) fell -104.35% since last year same period to -0.47 in the Q3 2022. This indicates that the Myovant Sciences Ltd has generated -104.35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-07-27 | -0.32 | -0.22 | 31.25% |
2022-05-11 | -0.57 | -0.63 | -10.53% |
2022-10-26 | -0.49 | -0.47 | 4.08% |
₹0 US Stocks a/c Opening Fee